Effect of Bhallatakadi Lepa in Treatment of Indralupta that is loss of hairs in patches.

A single-arm clinical study to evaluate the efficacy of the Bhallatakadi Lepa in the management of Indralupta with special reference to alopecia areata. - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/06/089842

Enrollment

Registered

2025-06-30

Start date

Unknown

Completion date

Unknown

Last updated

2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L639- Alopecia areata, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Diagnosed patients of Indralupta (alopecia areata) showing clinical findings as well circumscribed, bald patches on scalp measuring upto 5cm.

Exclusion criteria

Exclusion criteria: Pregnant women Patient on chemotherapy, radiotherapy Pitta prakruti Patients. Patients having khalitya, alopecia totalis, Alopecia Universalis, Traumatic Alopecia and androgenic Alopecia. Patient suffering from major mediccal illness. Patients having bald patches in beard and mustache.

Design outcomes

Primary

Measure	Time frame
To evaluate the efficacy of bhallatakadi Lepa in Indralupta.Timepoint: 7th, 14th, 21st day	—

Secondary

Measure	Time frame
To assess possible adverse drug reaction of bhallatakadi lepa.Timepoint: 7th day, 14th day, 21st day	—

Countries

India

Contacts

Public ContactDr Amol Sabale

MAMs Sumatibhai Shah Ayurved Mahavidyalaya Malwadi Hadapsar Pune

amolsabale09@gmail.com7276148765

Outcome results